Evangelatos, Gerasimos http://orcid.org/0000-0003-3822-3093
Bamias, Giorgos http://orcid.org/0000-0002-5492-5717
Kitas, George D. http://orcid.org/0000-0002-0828-6176
Kollias, George http://orcid.org/0000-0003-1867-3150
Sfikakis, Petros P. http://orcid.org/0000-0001-5484-2930
Article History
Received: 16 March 2022
Accepted: 12 April 2022
First Online: 3 May 2022
Declarations
: No part of this review, including ideas and tables, is copied or published elsewhere.
: GE declares no conflicts of interest for this review. GB has received advisor, lecturer and research grants from Abbvie, Adacyte Therapeutics, Aenorasis, Amgen, Cooper, Ferring, Genesis Pharma, Janssen, MSD, Mylan, Pfizer, Takeda, Vianex. GDK declares no conflicts of interest for this review. GK declares no conflicts of interest for this review. PPS has served as a consultant or on an advisory board and has received grant and research support from Abbvie, Actelion, Amgen, Boehringer Ingelheim, Enorasis, Faran, Pharmaserve-Lilly, Genesis Pharma, Gilead, Janssen, MSD, Novartis, Pfizer, Roche and UCB.
: Not applicable.
: Not applicable.
Free to read: This content has been made available to all.